Biotechnology
604 companies in this industry
Insider Buys (30d)
61
$39.84M
Insider Sells (30d)
349
$608.11M
Top Companies by Market Cap
VRTXVertex Pharmaceuticals Incorporated
$132.26BREGNRegeneron Pharmaceuticals, Inc.
$83.21BMRNAModerna, Inc.
$57.13BARGXargenx SE
$45.82BRVMDRevolution Medicines, Inc.
$44.15BALNYAlnylam Pharmaceuticals, Inc.
$34.52BROIVRoivant Sciences Ltd.
$29.49BINSMInsmed Incorporated
$28.05BINCYIncyte Corporation
$24.62BBNTXBioNTech SE
$24.56BRecent Insider Trades
| Date | Ticker | Company | Insider | Role | Type | Shares | Avg Price | Value |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | MAIA | MAIA Biotechnology, Inc. | Vitoc Vlad | director, 10 percent owner, officer: Chief Executive Officer | Buy | 73,000 | $1.37 | $100.0K |
| Sep 15, 2026 | PHVS | Pharvaris N.V. | Modig Berndt | director, officer: Chief Executive Officer | Sell | 2,291 | $39.40 | $90.3K |
| Sep 15, 2026 | AIM | AIM ImmunoTech Inc. | Equels Thomas K | director, officer: CEO & President | Buy | 5,900 | $0.22 | $1.3K |
| Sep 15, 2026 | UTHR | United Therapeutics Corporation | Mesa Nilda | director | Sell | 228 | $505.87 | $115.3K |
| Sep 15, 2026 | MIRM | Mirum Pharmaceuticals, Inc. | BJERKHOLT ERIC | officer: CHIEF FINANCIAL OFFICER | Sell | 9,943 | $98.37 | $978.1K |
| Sep 15, 2026 | HUMA | Humacyte, Inc. | Jones Keith Anthony | director | Buy | 10,000 | $0.56 | $5.6K |
| Sep 15, 2026 | IMNM | Immunome, Inc. | Higgins Jack | officer: Chief Scientific Officer | Sell | 13,200 | $25.32 | $334.2K |
| Sep 15, 2026 | UTHR | United Therapeutics Corporation | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 9,500 | $504.12 | $4.79M |
| Sep 15, 2026 | RVMD | Revolution Medicines, Inc. | Kelsey Stephen Michael | officer: See Remarks | Sell | 92,531 | $202.36 | $18.72M |
| Sep 15, 2026 | INBX | Inhibrx Biosciences Inc. | MANHARD KIMBERLY | director | Sell | 1,500 | $109.03 | $163.5K |
| Sep 15, 2026 | CYTK | Cytokinetics, Incorporated | Blum Robert I | director, officer: President & CEO | Sell | 105,426 | $69.62 | $7.34M |
| Sep 15, 2026 | PHVS | Pharvaris N.V. | Lu Peng | officer: President | Sell | 15,000 | $40.13 | $601.9K |
| Sep 15, 2026 | KRRO | Korro Bio, Inc. | FORMELA JEAN FRANCOIS | director | Sell | 48,690 | $14.09 | $686.2K |
| Sep 15, 2026 | IPSC | Century Therapeutics, Inc. | Carr Douglas | officer: SVP Finance & Operations | Sell | 1,658 | $1.93 | $3.2K |
| Sep 15, 2026 | ORKA | Oruka Therapeutics, Inc. | Quinlan Paul T | officer: General Counsel | Sell | 1,039 | $95.71 | $99.4K |
| Sep 15, 2026 | ORKA | Oruka Therapeutics, Inc. | Goncalves Joana | officer: Chief Medical Officer | Sell | 7,947 | $92.38 | $734.1K |
| Sep 15, 2026 | RARE | Ultragenyx Pharmaceutical Inc. | Huizenga Theodore Alan | officer: SVP, Chief Accounting Officer | Sell | 1,283 | $13.57 | $17.4K |
| Sep 15, 2026 | IRON | Disc Medicine, Inc. | Bitterman Kevin | director | Sell | 27,136 | $70.11 | $1.90M |
| Sep 15, 2026 | NBIX | Neurocrine Biosciences, Inc. | Boyer David W. | officer: Chief Corp. Affairs Officer | Sell | 826 | $157.45 | $130.1K |
| Sep 15, 2026 | CYTK | Cytokinetics, Incorporated | Landry Robert E | director | Sell | 1,000 | $72.13 | $72.1K |
| Sep 15, 2026 | ORKA | Oruka Therapeutics, Inc. | Sandler Laura Lee | officer: Chief Operating Officer | Sell | 906 | $95.71 | $86.7K |
| Sep 15, 2026 | ORKA | Oruka Therapeutics, Inc. | Agarwal Arjun | officer: Senior Vice President, Finance | Sell | 10,019 | $92.43 | $926.0K |
| Sep 15, 2026 | IPSC | Century Therapeutics, Inc. | Russotti Gregory | officer: See Remarks | Sell | 2,587 | $1.93 | $5.0K |
| Sep 15, 2026 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | Ben Yong | director | Sell | 2,000 | $7.84 | $15.7K |
| Sep 15, 2026 | NBIX | Neurocrine Biosciences, Inc. | ABERNETHY MATT | officer: Chief Financial Officer | Sell | 2,311 | $157.20 | $363.3K |
| Sep 15, 2026 | ORKA | Oruka Therapeutics, Inc. | Klein Lawrence Otto | director, officer: Chief Executive Officer | Sell | 2,452 | $95.71 | $234.7K |
| Sep 15, 2026 | RCKT | Rocket Pharmaceuticals, Inc. | Wilson Martin | officer: General Counsel | Sell | 75,364 | $3.40 | $256.5K |
| Sep 14, 2026 | ANIX | Anixa Biosciences, Inc. | KUMAR AMIT | director, officer: Chief Executive Officer | Buy | 3,000 | $2.75 | $8.3K |
| Sep 14, 2026 | ANIX | Anixa Biosciences, Inc. | Titterton Lewis H jr | director | Buy | 10,000 | $2.73 | $27.3K |
| Sep 14, 2026 | MAIA | MAIA Biotechnology, Inc. | Guerrero Ramiro | director | Buy | 37,595 | $1.32 | $49.5K |
| Sep 14, 2026 | AMLX | Amylyx Pharmaceuticals, Inc. | FRATES JAMES M | officer: Chief Financial Officer | Sell | 10,810 | $32.36 | $349.8K |
| Sep 14, 2026 | UTHR | United Therapeutics Corporation | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 9,500 | $500.82 | $4.76M |
| Sep 14, 2026 | AMLX | Amylyx Pharmaceuticals, Inc. | Bedrosian Camille L | officer: Chief Medical Officer | Sell | 10,028 | $32.40 | $324.9K |
| Sep 14, 2026 | TGTX | TG Therapeutics, Inc. | Charney Laurence N | director | Sell | 5,000 | $54.96 | $274.8K |
| Sep 14, 2026 | KRRO | Korro Bio, Inc. | Dolan Oliver | officer: Senior Vice President, Finance | Sell | 5 | $13.72 | $68.58 |
| Sep 14, 2026 | AMLX | Amylyx Pharmaceuticals, Inc. | Cohen Joshua B | director, officer: Co-Chief Executive Officer | Sell | 30,464 | $32.19 | $980.5K |
| Sep 14, 2026 | MRNA | Moderna, Inc. | Mock James M | officer: Chief Financial Officer | Sell | 34,836 | $134.49 | $4.69M |
| Sep 14, 2026 | LGND | Ligand Pharmaceuticals Incorporated | Zimmermann Martine | director | Sell | 1,200 | $285.00 | $342.0K |
| Sep 14, 2026 | RVMD | Revolution Medicines, Inc. | Mancini Anthony | officer: See Remarks | Sell | 15,448 | $204.16 | $3.15M |
| Sep 14, 2026 | AMLX | Amylyx Pharmaceuticals, Inc. | Mazzariello Gina | officer: Chief Legal Officer | Sell | 9,536 | $32.46 | $309.5K |
| Sep 14, 2026 | AMLX | Amylyx Pharmaceuticals, Inc. | Klee Justin B. | director, officer: Co-Chief Executive Officer | Sell | 30,464 | $32.18 | $980.3K |
| Sep 14, 2026 | RYTM | Rhythm Pharmaceuticals, Inc. | Meeker David P | director, officer: President and CEO | Sell | 50,000 | $102.67 | $5.13M |
| Sep 14, 2026 | MNKD | MannKind Corporation | Binder Steven B. | director | Sell | 33,558 | $3.81 | $127.9K |
| Sep 14, 2026 | PHVS | Pharvaris N.V. | Lesage Anne | officer: Chief Early Development | Sell | 30,000 | $38.30 | $1.15M |
| Sep 11, 2026 | TXG | 10x Genomics, Inc. | Taich Adam | officer: Chief Financial Officer | Sell | 46,388 | $64.57 | $3.00M |
| Sep 11, 2026 | CADL | Candel Therapeutics, Inc. | Tak Paul Peter | director, officer: Chief Executive Officer | Sell | 280,245 | $11.28 | $3.16M |
| Sep 11, 2026 | CYTK | Cytokinetics, Incorporated | Landry Robert E | director | Sell | 1,000 | $74.66 | $74.7K |
| Sep 11, 2026 | ANTX | AN2 Therapeutics, Inc. | Readnour Robin Shane | director | Sell | 1,108 | $6.02 | $6.7K |
| Sep 11, 2026 | OCGN | Ocugen, Inc. | Musunuri Shankar | director, officer: Chief Executive Officer | Sell | 525,991 | $1.12 | $589.1K |
| Sep 11, 2026 | RLMD | Relmada Therapeutics, Inc. | Shenouda Maged | officer: Chief Financial Officer | Buy | 200,000 | $4.22 | $844.0K |
Showing 1–50 of 410
1 / 9
...